Improvement of the diagnosis of allergy by using purified allergens

Clinical and Experimental Allergy

Volumn 36, Issue 12, 2006, Pages 1483-1486

  Scheurer, S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GLYCAN; IMMUNOGLOBULIN E; POLYGALACTURONASE; PROFILIN;

ALLERGY; CROSS ALLERGY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DISEASE SEVERITY; EDITORIAL; FOOD ALLERGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROVOCATION TEST; SKIN TEST;

ALLERGENS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INTRADERMAL TESTS; POLLEN; RADIOALLERGOSORBENT TEST; SENSITIVITY AND SPECIFICITY; TREES;

EID: 33845464174     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02597.x     Document Type: Editorial

References (42)

1. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H. The recombinant allergen-based concept of component-resolved diagnostics andimmunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896-904.
2. Lidholm J, Ballmer-Weber BK, Mari A, Vieths S. Component-resolved diagnostics in food allergy. Curr Opin Allergy Clin Immunol 2006; 6:234-40.
3. Ballmer-Weber BK, Scheurer S, Fritsche P et al. Component-resolved diagnosis with recombinant allergens in patients with cherry allergy. J Allergy Clin Immunol 2002; 110:167-73.
4. Mittag D, Vieths S, Vogel L et al. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens. J Allergy Clin Immunol 2004; 113:148-54.
5. Erdmann SM, Sachs B, Schmidt A et al. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test. Int Arch Allergy Immunol 2005; 136:230-8.
6. Reuter A, Lidholm J, Andersson K et al. A critical assessment of allergen component-based in vitro diagnosis in cherry allergy across Europe. Clin Exp Allergy 2006; 36:815-23.
7. Wensing M, Akkerdaas JH, van Leeuwen WA et al. IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance. J Allergy Clin Immunol 2002; 110:435-42.
8. Scheurer S, Wangorsch A, Nerkamp J et al. Cross-reactivity within the profilin panallergen family investigated by comparison of recombinant profilins from pear (Pyr c 4), cherry (Pru av 4) and celery (Api g 4) with birch pollen profilin Bet v 2. J Chromatogr B Biomed Sci Appl 2001; 756:315-25.
9. Mari A. IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol 2002; 129:286-95.
10. Asero R, Mistrello G, Roncarolo D et al. Detection of clinical markers of sensitization to profilin in patients allergic to plant-derived foods. J Allergy Clin Immunol 2003; 112:427-32.
11. Rodriguez R, Villalba M, Monsalve RI, Batanero E. The spectrum of olive pollen allergens. Int Arch Allergy Immunol 2001; 125:185-95.
12. Ballmer-Weber BK, Scheurer S, Fritsche P et al. Component-resolved diagnosis with recombinant allergens in patients with cherry allergy. J Allergy Clin Immunol 2002; 110:167-73.
13. Tresch S, Holzmann D, Baumann S et al. In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract. Clin Exp Allergy 2003; 33:1153-8.
14. Astier C, Morisset M, Roitel O et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol 2006; 118:250-6.
15. Niederberger V, Stubner P, Spitzauer S et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 2001; 117:848-51.
16. Mari A. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003; 33:43-51.
17. Hage-Hamsten M, Pauli G. Provocation testing with recombinant allergens. Methods 2004; 32:281-91.
18. Schmid-Grendelmeier P, Crameri R. Recombinant allergens for skin testing. Int Arch Allergy Immunol 2001; 125:96-111.
19. Quiralte J, Gonzalez E, Arias De Saavedra JM et al. Immunological activity of recombinant Ole e 1 in patients with Olea europaea pollinosis. Int Arch Allergy Immunol 2000; 122:101-7.
20. Heiss S, Mahler V, Steiner R et al. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol 1999; 113:830-7.
21. Schmid-Grendelmeier P, Holzmann D, Himly M et al. Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy. J Allergy Clin Immunol 2003; 111:1328-36.
22. Barderas R, Purohit A, Papanikolaou I, Rodriguez R, Pauli G, Villalba M. Cloning, expression, and clinical significance of the major allergen from ash pollen, Fra e 1. J Allergy Clin Immunol 2005; 115:351-7.
23. Asturias JA, Ibarrola I, Amat P et al. Purified allergens versus complete extract in the diagnosis of plane tree pollen allergy. Clin Exp Allergy 2006: 36:1505-12.
24. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 2002; 127:259-68.
25. Niederberger V, Pauli G, Grönlund H et al. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 1998; 102:579-91.
26. Niederberger V, Laffer S, Froschl R et al. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 1998; 101:258-64.
27. Suphioglu C. What are the important allergens in grass pollen that are linked to human allergic disease? Clin Exp Allergy 2000; 30:1335-41.
28. Stumvoll S, Westritschnig K, Lidholm J et al. Identification of cross-reactive and genuine Parietaria judaica pollen allergens. J Allergy Clin Immunol 2003; 111:974-9.
29. Enrique E, Alonso R, Bartolome B et al. IgE reactivity to profilin in platanus acerifolia pollen-sensitized subjects with plant-derived food allergy. J Invest Allergol Clin Immunol 2004; 14:335-42.
30. van Ree R. Isoallergen: a clinically relevant phenomenon or just a product of cloning? Clin Exp Allergy 2002; 32:975-8.
31. Reuter A, Fortunato D, Garoffo LP et al. Novel isoforms of Pru av 1 with diverging immunoglobulin E binding properties identified by a synergistic combination of molecular biology and proteomics. Proteomics 2005; 5:282-9.
32. Swoboda I, Jilek A, Ferreira F et al. Isoforms of Bet v. 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem 1995; 270:2607-13.
33. Ballmer-Weber BK, Wangorsch A, Bohle B et al. Component-resolved in vitro diagnosis in carrot allerg: does the use of recombinant carrot allergens improve the reliability of the diagnostic procedure? Clin Exp Allergy 2005; 35:970-8.
34. Deinhofer K, Sevcik H, Balic N et al. Microarrayed allergens for IgE profiling. Methods 2004; 32:249-54.
35. Fall BI, Eberlein-Konig B, Behrendt H, Niessner R, Ring J, Weller MG. Microarrays for the screening of allergen-specific IgE in human serum. Anal Chem 2003; 75:556-62.
36. Harwanegg C, Laffer S, Hiller R et al. Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 2003; 33:7-13.
37. Harwanegg C, Hiller R. Protein microarrays in diagnosing IgE-mediated diseases: spotting allergy at the molecular level. Expert Rev Mol Diagn 2004; 4:539-48.
38. Hiller R, Laffer S, Harwanegg C et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16:414-6.
39. Wohrl S, Vigl K, Zehetmayer S et al. The performance of a component-based allergen-microarray in clinical practice. Allergy 2006; 61:633-9.
40. Moverare R, Elfman L, Vesterinen E, Metso T, Haahtela T. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002; 57:423-30.
41. Sastre J, Raulf-Heimsoth M, Rihs HP et al. IgE reactivity to latex allergens among sensitized healthcare workers before and after immunotherapy with latex. Allergy 2006; 61:206-10.
42. Pittner G, Vrtala S, Thomas WR et al. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy 2004; 34:597-603.